Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Bronchopulmonary Dysplasia

• Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease
• Pragmatic Research on Diuretic Management in Early BPD Pilot
• Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia
• The Caffeine Therapy in the Fetal to Neonatal Transition
• Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease
• The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant
• Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
• Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
• Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial
• Inhaled Treatment for Bronchopulmonary Dysplasia
• Inhaled Tobramycin in BPD
• The Budesonide in Babies (BiB) Trial
• Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia
• Autologous Cord Blood Cells for Prevention of BPD in Preterm
• Zinc Supplementation on Very Low Birth Weight Infant
• Budesonide With Intratracheal Surfactants in Extremely Preterm Infants
• Nebulized Furosemide in Premature Infants With Bronchopulmonary Dysplasia - A Cross Over Pilot Study of Its Efficacy and Safety
• Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants
• Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia
• Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia
• Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus
• Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)
• Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia
• Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
• Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia
• L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia
• Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
• Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia
• Stem Cells for Bronchopulmonary Dysplasia
• Intratracheal Budesonide/Surfactant Prevents BPD
• A Clinical Efficacy and Safety Study of SHP607 in Preventing Chronic Lung Disease in Extremely Premature Infants
• Safety of Sildenafil in Premature Infants
• Early Caffeine in Preterm Neonates
• Fluid Filled Lung Oxygenation Assistance Trial
• Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates
• Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial
• Antibiotic "Dysbiosis" in Preterm Infants
• Aerosolized Albuterol Use in Severe BPD
• Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
• Early Versus Late Caffeine for ELBW Newborns
• Preterm Infant Inhaled Albuterol Dosing
• TINN2: Treat Infection in NeoNates 2
• MRI as a Means to Measure Lung Function: Non-Invasive Imaging in Neonates and Children
• No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
• Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
• Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study
• Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants
• Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease
• The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia
• Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis
• Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
• Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)
• Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)
• Hydrocortisone for BPD
• Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.
• Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
• Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
• Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
• Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
• Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
• Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia
• Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
• Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
• Prevention of Chronic Lung Disease (CLD) in Preterm Infants
• Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants
• PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates
• Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
• Inhaled Nitric Oxide and Neuroprotection in Premature Infants
• Montelukast in Very Low Birthweight Infants
• Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
• Trial II of Lung Protection With Azithromycin in the Preterm Infant
• Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity
• Surfactant Positive Airway Pressure and Pulse Oximetry Trial
• SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.
• Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates
• Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants
• Dexamethasone Therapy in VLBW Infants at Risk of CLD
• Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
• Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
• Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia
• Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
• Inhaled Beclomethasone to Prevent Chronic Lung Disease